Vimarsana
Biggest News Aggregation in the World

Component Summary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Component Summary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Component Summary Today - Breaking & Trending Today

Worse Outcomes Seen for Severe Bilateral Hip OA in Adult Spinal Deformity - Vimarsana News

Worse Outcomes Seen for Severe Bilateral Hip OA in Adult Spinal Deformity

For patients with adult spinal deformity (ASD), those with severe bilateral hip osteoarthritis (OA) have worse outcomes.

Shockwave Therapy Shows Benefit in Lower Limb Claudication - Vimarsana News

Shockwave Therapy Shows Benefit in Lower Limb Claudication

Sessions improved physical function and walking distance at 12 weeks

Intravenous Secukinumab Demonstrates Long-Term Safety and Efficacy for Active Axial Spondyloarthritis - Vimarsana News

Intravenous Secukinumab Demonstrates Long-Term Safety and Efficacy for Active Axial Spondyloarthritis

Treatment with IV SEC demonstrated safety and efficacy through 52 weeks among adult patients with active axSpA.

Source: empr.com
Tofacitinib-Treated Women With PsA Less Likely to Achieve MDA - Vimarsana News

Tofacitinib-Treated Women With PsA Less Likely to Achieve MDA

At month 3, patients treated with tofacitinib achieved higher rates of ACR20/50, MDA, and PASI75 in both sexes when compared with the placebo. However, female patients were less likely to achieve MDA when compared with males.

Outcomes in Nontransfusion-Dependent β-Thalassemia With Luspatercept or Placebo - Vimarsana News

Outcomes in Nontransfusion-Dependent β-Thalassemia With Luspatercept or Placebo

Researchers determined luspatercept may improve outcomes in patients with nontransfusion-dependent β-thalassemia.

Source: empr.com